Abstract 14434: Impact of Linagliptin on Cardiovascular (CV) Risk in Type 2 Diabetes (T2D): Insights From a Pre-defined CV Meta-Analysis

Incidence of CV events is increased in T2D but the potential for CV risk modulation with glucose-lowering agents is debated. Interestingly, several CV meta-analyses involving drugs from the class o...